NASDAQ: SMMT - Summit Therapeutics Inc.

Rentabilité sur six mois: +26.53%
Rendement en dividendes: 0%
Secteur: Healthcare

Nouvelles

2025 March Market Cap Showdown: Andy Cross vs. Matt Argersinger

10 marthe 18:55 2025 March Market Cap Showdown: Andy Cross vs. Matt Argersinger